1. Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases
    Debora Lo Furno et al, 2017, J Cell Physiol CrossRef
  2. Cell Therapy for Parkinson’s Disease
    Takao Yasuhara et al, 2017, Cell Transplant CrossRef
  3. Altered Tracer Distribution and Clearance in the Extracellular Space of the Substantia Nigra in a Rodent Model of Parkinson's Disease.
    Yuan Fang et al, 2017, Front Neurosci CrossRef
  4. Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington’s Disease
    Danielle A. Simmons, 2017, JHD CrossRef
  5. Dental Mesenchymal Stem/Stromal Cells and Their Exosomes
    Peter Stanko et al, 2018, Stem Cells International CrossRef
  6. Therapeutic efficacy of olfactory stem cells in rotenone induced Parkinsonism in adult male albino rats
    Mohammed Abdel-Rahman et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  7. The effects of local administration of mesenchymal stem cells on rat corneal allograft rejection
    Zhe Jia et al, 2018, BMC Ophthalmol CrossRef
  8. Roles of stem cells in the treatment of Parkinson's disease
    Yasaman Ebrahimikia et al, 2018, J Qazvin Univ Med Sci CrossRef
  9. Intranasal drug delivery: Novel delivery route for effective management of neurological disorders
    Ashwini Patel et al, 2019, Journal of Drug Delivery Science and Technology CrossRef
  10. Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson’s disease therapy
    Saeid Bagheri-Mohammadi et al, 2019, Mol Biol Rep CrossRef
  11. MicroRNA‐326 suppresses iNOS expression and promotes autophagy of dopaminergic neurons through the JNK signaling by targeting XBP1 in a mouse model of Parkinson's disease
    Xiao‐Hui Zhao et al, 2019, J Cell Biochem CrossRef
  12. Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease
    Libo Yu-Taeger et al, 2019, Cells CrossRef
  13. Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
    Henry Caplan et al, 2019, Front. Immunol. CrossRef
  14. Mesenchymal stem cells in chemotherapy‐induced peripheral neuropathy: A new challenging approach that requires further investigations
    Khaled F. Al‐Massri et al, 2019, J Tissue Eng Regen Med CrossRef
  15. Curcumin-Activated Mesenchymal Stem Cells Derived from Human Umbilical Cord and Their Effects on MPTP-Mouse Model of Parkinson’s Disease: A New Biological Therapy for Parkinson’s Disease
    Yun-Liang Wang et al, 2020, Stem Cells International CrossRef
  16. Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer’s Disease
    Shen Luo et al, 2020, Front. Cell. Neurosci. CrossRef
  17. Mesenchymal stromal cells; a new horizon in regenerative medicine
    Shirin Tavakoli et al, 2020, J Cell Physiol CrossRef
  18. Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice
    Giulia Santamaria et al, 2020, Cell Death Differ CrossRef
  19. Stem Cell Therapy for Neurodegenerative Diseases: How Do Stem Cells Bypass the Blood-Brain Barrier and Home to the Brain?
    Yvonne Cashinn Chia et al, 2020, Stem Cells International CrossRef
  20. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders
    Salman Ul Islam et al, 2020, Molecules CrossRef
  21. Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson’s disease
    Dominika Fričová et al, 2020, npj Regen Med CrossRef
  22. Effect and mechanism of human umbilical cord mesenchymal stem cells in treating allergic rhinitis in mice
    Xiao-li Kan et al, 2020, Sci Rep CrossRef
  23. Mesenchymal stem cells in Parkinson’s disease: Motor and nonmotor symptoms in the early posttransplant period
    Aliaksandr Boika et al, 2020 CrossRef
  24. Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia
    Nicola J. Robertson et al, 2020, Cytotherapy CrossRef
  25. Intranasal administration of small extracellular vesicles derived from mesenchymal stem cells ameliorated the experimental autoimmune encephalomyelitis
    Anwar Fathollahi et al, 2021, International Immunopharmacology CrossRef
  26. Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease
    Sara Simorgh et al, 2021, Neurotox Res CrossRef
  27. Mesenchymal Stem Cells for Neurological Disorders
    Anna Andrzejewska et al, 2021, Adv. Sci. CrossRef
  28. Advances in intranasal application of stem cells in the treatment of central nervous system diseases
    Yu-Ting Zhang et al, 2021, Stem Cell Res Ther CrossRef
  29. Neurotoxin-Induced Rodent Models of Parkinson’s Disease: Benefits and Drawbacks
    Mohamed El-Gamal et al, 2021, Neurotox Res CrossRef
  30. Magnetic Targeting of Human Olfactory Mucosa Stem Cells Following Intranasal Administration: a Novel Approach to Parkinson’s Disease Treatment
    Sara Simorgh et al, 2021, Mol Neurobiol CrossRef
  31. Intranasal delivery of mitochondria for treatment of Parkinson’s Disease model rats lesioned with 6-hydroxydopamine
    Jui-Chih Chang et al, 2021, Sci Rep CrossRef
  32. From Transcriptome to Behavior: Intranasal Injection of Late Passage Human Olfactory Stem Cells Displays Potential in a Rat Model of Parkinson’s Disease
    Rafieh Alizadeh et al, 2021, ACS Chem. Neurosci. CrossRef
  33. Developing a New Strategy for Delivery of Neural Transplant Populations Using Precursor Cell Sprays and Specialized Cell Media
    William A. Woods et al, 2021, Adv NanoBio Res CrossRef
  34. Evaluation of the association between periodontitis and risk of Parkinson’s disease: a nationwide retrospective cohort study
    Eunkyung Jeong et al, 2021, Sci Rep CrossRef
  35. Therapeutic potentials of human microfluidic encapsulated conjunctival mesenchymal stem cells on the rat model of Parkinson's disease
    Meysam Forouzandeh et al, 2021, Experimental and Molecular Pathology CrossRef
  36. Human Umbilical Cord Mesenchymal Stem Cells Improve Locomotor Function in Parkinson’s Disease Mouse Model Through Regulating Intestinal Microorganisms
    Zhengqin Sun et al, 2022, Front. Cell Dev. Biol. CrossRef
  37. Mesenchymal Stromal Cells Preconditioning: A New Strategy to Improve Neuroprotective Properties
    Giovanni Schepici et al, 2022, IJMS CrossRef
  38. New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: combining with intranasal delivery
    Yaosheng Li et al, 2022, Acta Pharmaceutica Sinica B CrossRef
  39. Application of olfactory ensheathing cells in clinical treatment of spinal cord injury: meta-analysis and prospect
    Huijing Chen et al, 2019, Journal of Neurorestoratology CrossRef
  40. Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects
    Mohaddeseh Rahbaran et al, 2022, Cell Mol Biol Lett CrossRef
  41. The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment
    Reza Mosaddeghi Heris et al, 2022, Stem Cell Res Ther CrossRef